First Comparison of Amulet and Watchman FLX LAA Closure Devices

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

TCT DAIC

Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Structural Heart Occluders

Diagnostic and Interventional Cardiology

Structural Heart Occluders

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Diagnostic and Interventional Cardiology

Structural Heart Occluders

Left Atrial Appendage (LAA) Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology